ASCO 2025 – AI in HER2-Low Detection with Dr. Marina De Brot

Dr. Marina De Brot presents their work showcased at ASCO 2025 on using AI to improve detection of HER2-low and HER2-ultralow breast cancer, enhancing diagnostic accuracy and expanding eligibility for HER2-targeted treatments.